US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

19.87

+0.27001.38%

Volume:11.64M

Turnover:229.24M

Market Cap:13.57B

PE:-28.71

High:19.89

Open:19.33

Low:19.32

Close:19.60

52wk High:20.09

52wk Low:8.73

Shares:683.00M

Float Shares:414.56M

Volume Ratio:1.32

T/O Rate:2.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6921

EPS(LYR):-0.2371

ROE:-18.15%

ROA:-12.59%

PB:3.12

PE(LYR):-83.81

Loading ...

Overview Company News Filings

Guggenheim Keeps Their Buy Rating on Roivant Sciences (ROIV)

Roivant Sciences Up Over 11%, on Track for Record High Close -- Data Talk

Roivant Sciences Shares up 12.2% After Co Reports Positive Trial Data for Skin, Muscle Disease Drug

THOMSON REUTERS

Roivant Sciences rises 12.0%

Roivant, Priovant Say Dermatomyositis Treatment Meets Main Goal in Phase 3 Study; Shares up Pre-Bell

MT Newswires Live

Roivant Shares Rise On Positive Data for Autoimmune Disease Drug

Roivant Sciences Ltd - Nda Filing for Brepocitinib Planned for 1H 2026

THOMSON REUTERS

Roivant and Priovant Announce Positive Phase 3 Valor Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (Dm)

THOMSON REUTERS

Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock -- Barrons.com

Roivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent Challenges

Simply Wall St.

BRIEF-Roivant Named On Fortune Media And Great Place To Work’s 2025 Best Workplaces In Biopharma List

Roivant Sciences Ltd. Conducted Its Annual General Meeting of Shareholders

Roivant Named on Fortune Media and Great Place to Work’s 2025 Best Workplaces in Biopharma List

THOMSON REUTERS

Vivek Ramaswamy, 10% Owner, Reports Disposal of Common Shares in Roivant Sciences Ltd

Roivant Sciences' Mosliciguat Granted Orphan Drug Designation in Japan

MT Newswires Live

Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)

THOMSON REUTERS

Roivant Sciences Unveils Promising Six-Month Remission Data for Potentially Transformative Graves' Disease Therapy

Roivant Unveils Durability and Treatment-Free Six-Month Remission Data With Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients

THOMSON REUTERS

Roivant Sciences Initiated at Buy by Citigroup

Stock Track | Roivant Sciences Plummets 5.13% as Q1 Losses Exceed Expectations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ROIV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ROIV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":19.87,"timestamp":1762290000000,"preClose":19.6,"halted":0,"volume":11643067,"delay":0,"floatShares":414556768,"shares":683000000,"eps":-0.692075,"marketStatus":"Pre-Mkt","change":0.27,"latestTime":"11-05 06:56:43 EST","open":19.325,"high":19.89,"low":19.315,"amount":229241335.82369497,"amplitude":0.029337,"askPrice":19.89,"askSize":360,"bidPrice":16.01,"bidSize":55,"shortable":3,"etf":0,"ttmEps":-0.692075,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762353000000},"marketStatusCode":1,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":19.87,"postHourTrading":{"tag":"盘后","latestPrice":19.42,"preClose":19.87,"latestTime":"19:54 EST","volume":174282,"amount":3462687.3445,"timestamp":1762304043977},"volumeRatio":1.3249991743884941,"impliedVol":0.5104,"impliedVolPercentile":0.9398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ROIV\",,,,,undefined,":{"symbol":"ROIV","floatShares":414556768,"roa":"-12.59%","roe":"-18.15%","lyrEps":-0.237085,"volumeRatio":1.3249991743884941,"shares":683000000,"dividePrice":0,"high":19.89,"amplitude":0.029337,"preClose":19.6,"low":19.315,"week52Low":8.73,"pbRate":"3.12","psRate":"584.14","week52High":20.085,"institutionHeld":0,"latestPrice":19.87,"committee":-0.73494,"eps":-0.692075,"divideRate":0,"volume":11643067,"delay":0,"ttmEps":-0.692075,"open":19.325,"prevYearClose":11.83,"prevWeekClose":19.99,"prevMonthClose":19.99,"prevQuarterClose":15.13,"fiveDayClose":18.41,"twentyDayClose":16.12,"sixtyDayClose":11.17,"earningDate":1762704000000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ROIV\",params:#limit:5,,,undefined,":[{"date":"2025-11-10","symbol":"ROIV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"defaultRemindTime":1762765200000,"name":null,"time":"Pre-Market","dateTimestamp":1762750800000,"actualEps":null},{"market":"US","date":"2025-08-11","symbol":"ROIV","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2025-05-29","symbol":"ROIV","fiscalQuarterEnding":"2025/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2025-02-10","symbol":"ROIV","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-12","symbol":"ROIV","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ROIV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ROIV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1756789200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ROIV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ROIV","date":"2025-11-03","current":-28.710761,"percent":0.131857,"low":-71.097356,"twenty":-9.32108,"median":-4.632542,"eighty":1.752882,"high":2.128992,"avg":-11.197934,"sd":18.991302,"marketCap":13810888221},"quantilePoints":[{"date":"2021-10-01","current":-7.393592,"twenty":-7.393592,"median":-7.393592,"eighty":-7.393592,"marketCap":6566796009},{"date":"2021-10-08","current":-5.068762,"twenty":-7.200647,"median":-5.392973,"eighty":-5.011828,"marketCap":4501942504},{"date":"2021-10-15","current":-4.760366,"twenty":-6.226432,"median":-5.064808,"eighty":-4.897958,"marketCap":4228033366},{"date":"2021-10-22","current":-5.377158,"twenty":-5.411951,"median":-4.997594,"eighty":-4.833116,"marketCap":4775851643},{"date":"2021-10-29","current":-6.278622,"twenty":-6.291275,"median":-5.22296,"eighty":-4.848931,"marketCap":5576509124},{"date":"2021-11-05","current":-6.120471,"twenty":-6.278622,"median":-5.416696,"eighty":-4.897958,"marketCap":5436042899},{"date":"2021-11-12","current":-6.642371,"twenty":-6.291275,"median":-5.970226,"eighty":-4.945404,"marketCap":5899581441},{"date":"2021-11-19","current":-5.294334,"twenty":-6.278622,"median":-5.426692,"eighty":-4.965964,"marketCap":5618648992},{"date":"2021-11-26","current":-4.632542,"twenty":-6.278622,"median":-5.392973,"eighty":-4.942241,"marketCap":4916317868},{"date":"2021-12-03","current":-5.94289,"twenty":-6.246992,"median":-5.404834,"eighty":-4.886887,"marketCap":6306933493},{"date":"2021-12-10","current":-5.9098,"twenty":-6.278622,"median":-5.56694,"eighty":-4.942241,"marketCap":6271816937},{"date":"2021-12-17","current":-7.24662,"twenty":-6.278622,"median":-5.70859,"eighty":-4.958056,"marketCap":7690525807},{"date":"2021-12-23","current":-7.915029,"twenty":-6.461382,"median":-5.896565,"eighty":-4.962362,"marketCap":8399880243},{"date":"2021-12-31","current":-6.670861,"twenty":-6.679397,"median":-5.936272,"eighty":-4.990763,"marketCap":7079497729},{"date":"2022-01-07","current":-5.658319,"twenty":-6.654395,"median":-5.93348,"eighty":-5.048202,"marketCap":6004931110},{"date":"2022-01-14","current":-5.261244,"twenty":-6.643953,"median":-5.883329,"eighty":-5.051959,"marketCap":5583532435},{"date":"2022-01-21","current":-4.79799,"twenty":-6.611816,"median":-5.850239,"eighty":-4.961285,"marketCap":5091900649},{"date":"2022-01-28","current":-4.420769,"twenty":-6.571592,"median":-5.612629,"eighty":-4.867909,"marketCap":4691571908},{"date":"2022-02-04","current":-4.718575,"twenty":-6.480662,"median":-5.4664,"eighty":-4.79799,"marketCap":5007620914},{"date":"2022-02-11","current":-4.533273,"twenty":-6.411262,"median":-5.421694,"eighty":-4.75404,"marketCap":4810968199},{"date":"2022-02-18","current":-4.229896,"twenty":-6.336473,"median":-5.386985,"eighty":-4.697398,"marketCap":4588438579},{"date":"2022-02-25","current":-4.197996,"twenty":-6.294119,"median":-5.373749,"eighty":-4.638618,"marketCap":4553834970},{"date":"2022-03-04","current":-3.611042,"twenty":-6.287633,"median":-5.300952,"eighty":-4.614157,"marketCap":3917128561},{"date":"2022-03-11","current":-3.209106,"twenty":-6.278622,"median":-5.214919,"eighty":-4.599453,"marketCap":3481123085},{"date":"2022-03-18","current":-3.311185,"twenty":-6.26597,"median":-5.064808,"eighty":-4.551803,"marketCap":3591854634},{"date":"2022-03-25","current":-3.177207,"twenty":-6.224851,"median":-4.997594,"eighty":-4.245208,"marketCap":3446519476},{"date":"2022-04-01","current":-3.087888,"twenty":-6.188476,"median":-4.960747,"eighty":-4.132921,"marketCap":3349629370},{"date":"2022-04-08","current":-2.647672,"twenty":-6.180568,"median":-4.886887,"eighty":-3.804992,"marketCap":2872099563},{"date":"2022-04-14","current":-2.580683,"twenty":-6.166298,"median":-4.831534,"eighty":-3.511515,"marketCap":2799431984},{"date":"2022-04-22","current":-2.494554,"twenty":-6.126648,"median":-4.804608,"eighty":-3.330325,"marketCap":2706002239},{"date":"2022-04-29","current":-2.354195,"twenty":-6.120471,"median":-4.79799,"eighty":-3.283114,"marketCap":2553746358},{"date":"2022-05-06","current":-2.309536,"twenty":-6.09833,"median":-4.74149,"eighty":-3.183587,"marketCap":2505301306},{"date":"2022-05-13","current":-2.207457,"twenty":-5.999036,"median":-4.718575,"eighty":-3.099372,"marketCap":2394569756},{"date":"2022-05-20","current":-2.360575,"twenty":-5.953479,"median":-4.649087,"eighty":-2.763787,"marketCap":2560667080},{"date":"2022-05-27","current":-2.577493,"twenty":-5.941566,"median":-4.632542,"eighty":-2.637464,"marketCap":2795971623},{"date":"2022-06-03","current":-2.781651,"twenty":-5.936272,"median":-4.625924,"eighty":-2.634912,"marketCap":3017434722},{"date":"2022-06-10","current":-2.469034,"twenty":-5.930689,"median":-4.602882,"eighty":-2.583873,"marketCap":2678319352},{"date":"2022-06-17","current":-2.794411,"twenty":-5.9098,"median":-4.599453,"eighty":-2.577493,"marketCap":3031276165},{"date":"2022-06-24","current":-3.055988,"twenty":-5.888623,"median":-4.592835,"eighty":-2.577493,"marketCap":3315025761},{"date":"2022-07-01","current":-3.664409,"twenty":-5.883329,"median":-4.477021,"eighty":-2.580045,"marketCap":3097385357},{"date":"2022-07-08","current":-4.01261,"twenty":-5.863475,"median":-4.327927,"eighty":-2.582597,"marketCap":3391707043},{"date":"2022-07-15","current":-3.540051,"twenty":-5.794648,"median":-4.223516,"eighty":-2.595357,"marketCap":2992270469},{"date":"2022-07-22","current":-3.564922,"twenty":-5.698027,"median":-4.143766,"eighty":-2.610669,"marketCap":3013293447},{"date":"2022-07-29","current":-3.311167,"twenty":-5.603492,"median":-4.012978,"eighty":-2.627256,"marketCap":2798803556},{"date":"2022-08-05","current":-3.136457,"twenty":-5.546323,"median":-3.998124,"eighty":-2.642568,"marketCap":2651127991},{"date":"2022-08-12","current":-3.635628,"twenty":-5.492872,"median":-3.896543,"eighty":-2.647672,"marketCap":3073058176},{"date":"2022-08-19","current":-2.37779,"twenty":-5.442575,"median":-3.739024,"eighty":-2.627256,"marketCap":2603414024},{"date":"2022-08-26","current":-2.409923,"twenty":-5.426692,"median":-3.722442,"eighty":-2.582597,"marketCap":2638595295},{"date":"2022-09-02","current":-2.262114,"twenty":-5.420694,"median":-3.686206,"eighty":-2.571113,"marketCap":2476761450},{"date":"2022-09-09","current":-2.319952,"twenty":-5.407207,"median":-3.656118,"eighty":-2.54405,"marketCap":2540087737},{"date":"2022-09-16","current":-2.0886,"twenty":-5.390578,"median":-3.622956,"eighty":-2.522626,"marketCap":2286782589},{"date":"2022-09-23","current":-1.923582,"twenty":-5.383054,"median":-3.581602,"eighty":-2.479242,"marketCap":2106106321},{"date":"2022-09-30","current":-2.071549,"twenty":-5.375794,"median":-3.540051,"eighty":-2.458826,"marketCap":2268114499},{"date":"2022-10-07","current":-2.830689,"twenty":-5.36316,"median":-3.496169,"eighty":-2.456274,"marketCap":3099286894},{"date":"2022-10-14","current":-2.946489,"twenty":-5.331394,"median":-3.460918,"eighty":-2.458826,"marketCap":3226075903},{"date":"2022-10-21","current":-2.856422,"twenty":-5.302276,"median":-3.442407,"eighty":-2.462654,"marketCap":3127462229},{"date":"2022-10-28","current":-3.377526,"twenty":-5.281098,"median":-3.377526,"eighty":-2.464697,"marketCap":3698012771},{"date":"2022-11-04","current":-3.538361,"twenty":-5.242714,"median":-3.39361,"eighty":-2.46827,"marketCap":3874108617},{"date":"2022-11-11","current":-3.413882,"twenty":-5.212272,"median":-3.409693,"eighty":-2.479242,"marketCap":3737818266},{"date":"2022-11-18","current":-3.079035,"twenty":-5.152485,"median":-3.375884,"eighty":-2.494554,"marketCap":3627093935},{"date":"2022-11-25","current":-3.177564,"twenty":-5.06718,"median":-3.35355,"eighty":-2.494554,"marketCap":3743160940},{"date":"2022-12-02","current":-3.879584,"twenty":-5.051959,"median":-3.352764,"eighty":-2.499658,"marketCap":4570138358},{"date":"2022-12-09","current":-4.310649,"twenty":-5.012624,"median":-3.375884,"eighty":-2.52135,"marketCap":5077931509},{"date":"2022-12-16","current":-4.507707,"twenty":-4.994734,"median":-3.411571,"eighty":-2.52773,"marketCap":5310065520},{"date":"2022-12-23","current":-4.316807,"twenty":-4.979321,"median":-3.429759,"eighty":-2.532833,"marketCap":5085185696},{"date":"2022-12-30","current":-4.920298,"twenty":-4.963438,"median":-3.442407,"eighty":-2.532833,"marketCap":5796096108},{"date":"2023-01-06","current":-5.696215,"twenty":-4.986152,"median":-3.459421,"eighty":-2.537937,"marketCap":6710123779},{"date":"2023-01-13","current":-6.078015,"twenty":-5.062436,"median":-3.489823,"eighty":-2.548887,"marketCap":7159883427},{"date":"2023-01-20","current":-5.406785,"twenty":-5.233449,"median":-3.502516,"eighty":-2.555534,"marketCap":6369176949},{"date":"2023-01-27","current":-5.26515,"twenty":-5.262806,"median":-3.539206,"eighty":-2.566009,"marketCap":6202330628},{"date":"2023-02-03","current":-4.803295,"twenty":-5.259893,"median":-3.564922,"eighty":-2.571113,"marketCap":5658266538},{"date":"2023-02-10","current":-5.115464,"twenty":-5.244212,"median":-3.604662,"eighty":-2.574941,"marketCap":6026001052},{"date":"2023-02-17","current":-5.249117,"twenty":-5.262806,"median":-3.622956,"eighty":-2.577493,"marketCap":6537643757},{"date":"2023-02-24","current":-4.707155,"twenty":-5.260343,"median":-3.647828,"eighty":-2.578769,"marketCap":5862643415},{"date":"2023-03-03","current":-4.902017,"twenty":-5.255042,"median":-3.686206,"eighty":-2.581959,"marketCap":6105340167},{"date":"2023-03-10","current":-4.658439,"twenty":-5.243214,"median":-3.722442,"eighty":-2.58884,"marketCap":5801969227},{"date":"2023-03-17","current":-5.297833,"twenty":-5.243214,"median":-3.739024,"eighty":-2.598979,"marketCap":6598317945},{"date":"2023-03-24","current":-4.213908,"twenty":-5.243214,"median":-3.8468,"eighty":-2.606589,"marketCap":5248317262},{"date":"2023-03-31","current":-4.494023,"twenty":-5.232955,"median":-3.897301,"eighty":-2.613481,"marketCap":5597193843},{"date":"2023-04-06","current":-4.329608,"twenty":-5.228412,"median":-3.950432,"eighty":-2.619601,"marketCap":5392418458},{"date":"2023-04-14","current":-4.627992,"twenty":-5.217919,"median":-4.01261,"eighty":-2.637464,"marketCap":5764047860},{"date":"2023-04-21","current":-5.358727,"twenty":-5.233657,"median":-4.051523,"eighty":-2.647672,"marketCap":6674160680},{"date":"2023-04-28","current":-5.133417,"twenty":-5.258992,"median":-4.076932,"eighty":-2.647672,"marketCap":6393542560},{"date":"2023-05-05","current":-5.115149,"twenty":-5.249117,"median":-4.210756,"eighty":-2.654052,"marketCap":6370789740},{"date":"2023-05-12","current":-5.510964,"twenty":-5.261296,"median":-4.226706,"eighty":-2.654128,"marketCap":6863767517},{"date":"2023-05-19","current":-5.535322,"twenty":-5.302098,"median":-4.268175,"eighty":-2.724231,"marketCap":6894104611},{"date":"2023-05-26","current":-5.620574,"twenty":-5.32219,"median":-4.304491,"eighty":-2.730611,"marketCap":7000284440},{"date":"2023-05-31","current":-5.523143,"twenty":-5.32219,"median":-4.313728,"eighty":-2.730611,"marketCap":6878936064},{"date":"2023-06-09","current":-5.833705,"twenty":-5.36774,"median":-4.329608,"eighty":-2.730865,"marketCap":7265734013},{"date":"2023-06-16","current":-6.040747,"twenty":-5.386985,"median":-4.34784,"eighty":-2.731246,"marketCap":7523599312},{"date":"2023-06-23","current":-6.071194,"twenty":-5.402439,"median":-4.369153,"eighty":-2.743893,"marketCap":7561520679},{"date":"2023-06-30","current":-7.523496,"twenty":-5.414714,"median":-4.379957,"eighty":-2.752698,"marketCap":7591433186},{"date":"2023-07-07","current":-8.093458,"twenty":-5.42245,"median":-4.39535,"eighty":-2.763985,"marketCap":8166541761},{"date":"2023-07-10","current":-8.20745,"twenty":-5.426692,"median":-4.40302,"eighty":-2.769628,"marketCap":8281563476},{"date":"2023-07-21","current":-8.458233,"twenty":-5.426692,"median":-4.411894,"eighty":-2.775271,"marketCap":8534611249},{"date":"2023-07-28","current":-8.20745,"twenty":-5.456159,"median":-4.423904,"eighty":-2.776851,"marketCap":8281563476},{"date":"2023-08-02","current":-9.084475,"twenty":-5.504874,"median":-4.43381,"eighty":-2.779221,"marketCap":9166507826},{"date":"2023-08-11","current":-8.673275,"twenty":-5.533128,"median":-4.451397,"eighty":-2.781165,"marketCap":8751594647},{"date":"2023-08-17","current":-8.609097,"twenty":-5.568907,"median":-4.464601,"eighty":-2.789307,"marketCap":8342533149},{"date":"2023-08-25","current":-8.848017,"twenty":-5.635672,"median":-4.494023,"eighty":-2.794411,"marketCap":8574055808},{"date":"2023-09-01","current":-9.214361,"twenty":-5.70006,"median":-4.494023,"eighty":-2.796878,"marketCap":8929057219},{"date":"2023-09-08","current":-9.317894,"twenty":-5.725205,"median":-4.506954,"eighty":-2.804955,"marketCap":9029383704},{"date":"2023-09-15","current":-9.150649,"twenty":-5.757588,"median":-4.518382,"eighty":-2.830689,"marketCap":8867317843},{"date":"2023-09-19","current":-8.855981,"twenty":-5.782386,"median":-4.524471,"eighty":-2.831089,"marketCap":8581773230},{"date":"2023-10-05","current":-7.985677,"twenty":-5.795976,"median":-4.528872,"eighty":-2.831489,"marketCap":7738416687},{"date":"2023-10-09","current":-8.819584,"twenty":-5.801844,"median":-4.533273,"eighty":-2.83189,"marketCap":8546503125},{"date":"2023-11-10","current":-6.982171,"twenty":-5.878767,"median":-4.593193,"eighty":-2.839209,"marketCap":6765981641},{"date":"2023-11-17","current":-7.385988,"twenty":-5.911027,"median":-4.599453,"eighty":-2.843555,"marketCap":7251370631},{"date":"2023-11-24","current":-7.476061,"twenty":-5.936844,"median":-4.606312,"eighty":-2.848702,"marketCap":7339801980},{"date":"2023-12-01","current":-7.828164,"twenty":-5.955617,"median":-4.626958,"eighty":-2.858995,"marketCap":7685488163},{"date":"2023-12-08","current":-7.983745,"twenty":-6.044634,"median":-4.632542,"eighty":-2.865429,"marketCap":7838233221},{"date":"2023-12-15","current":-9.113752,"twenty":-6.115375,"median":-4.64756,"eighty":-2.880169,"marketCap":8947644692},{"date":"2023-12-22","current":-8.630633,"twenty":-6.163796,"median":-4.652396,"eighty":-2.903623,"marketCap":8473331092},{"date":"2023-12-29","current":-9.310275,"twenty":-6.191639,"median":-4.65697,"eighty":-2.914323,"marketCap":9140585817},{"date":"2024-01-05","current":-8.85991,"twenty":-6.278622,"median":-4.665632,"eighty":-2.914323,"marketCap":8698429071},{"date":"2024-01-12","current":-8.999114,"twenty":-6.411262,"median":-4.682797,"eighty":-2.933623,"marketCap":8835095702},{"date":"2024-01-19","current":-8.606068,"twenty":-6.622001,"median":-4.702881,"eighty":-2.951636,"marketCap":8449213451},{"date":"2024-01-26","current":-8.614256,"twenty":-6.787201,"median":-4.725193,"eighty":-2.964833,"marketCap":8457252665},{"date":"2024-02-02","current":-8.229399,"twenty":-7.069423,"median":-4.752459,"eighty":-2.973569,"marketCap":8079409627},{"date":"2024-02-09","current":-8.655198,"twenty":-7.254542,"median":-4.792407,"eighty":-2.978932,"marketCap":8497448732},{"date":"2024-02-16","current":2.065844,"twenty":-7.303922,"median":-4.780228,"eighty":-2.964833,"marketCap":9226936768},{"date":"2024-02-23","current":2.049606,"twenty":-7.257183,"median":-4.752459,"eighty":-2.914323,"marketCap":9154410628},{"date":"2024-03-01","current":2.06404,"twenty":-7.238464,"median":-4.725193,"eighty":-2.857709,"marketCap":9218878308},{"date":"2024-03-08","current":2.011717,"twenty":-7.203572,"median":-4.702881,"eighty":-2.831089,"marketCap":8985182966},{"date":"2024-03-15","current":1.845728,"twenty":-7.17056,"median":-4.682797,"eighty":-2.784203,"marketCap":8243804641},{"date":"2024-03-22","current":1.851141,"twenty":-7.072124,"median":-4.662035,"eighty":-2.734408,"marketCap":8267980021},{"date":"2024-03-28","current":1.955786,"twenty":-7.061318,"median":-4.653949,"eighty":-2.724231,"marketCap":8735370705},{"date":"2024-04-05","current":2.07667,"twenty":-7.041464,"median":-4.649343,"eighty":-2.647672,"marketCap":9275287529},{"date":"2024-04-12","current":2.015326,"twenty":-6.982171,"median":-4.633193,"eighty":-2.603013,"marketCap":9001299887},{"date":"2024-04-19","current":1.869183,"twenty":-6.836309,"median":-4.627992,"eighty":-2.577493,"marketCap":8348564622},{"date":"2024-04-26","current":1.963003,"twenty":-6.71354,"median":-4.606312,"eighty":-2.558353,"marketCap":8767604545},{"date":"2024-05-03","current":2.027955,"twenty":-6.670861,"median":-4.599453,"eighty":-2.532833,"marketCap":9057709107},{"date":"2024-05-10","current":2.02976,"twenty":-6.650279,"median":-4.593193,"eighty":-2.494554,"marketCap":9065767567},{"date":"2024-05-17","current":2.058627,"twenty":-6.642371,"median":-4.533273,"eighty":-2.462654,"marketCap":9194702928},{"date":"2024-05-24","current":1.973829,"twenty":-6.591446,"median":-4.51,"eighty":-2.454908,"marketCap":8815955305},{"date":"2024-05-31","current":1.718448,"twenty":-6.564974,"median":-4.500113,"eighty":-2.434582,"marketCap":7675319574},{"date":"2024-06-07","current":1.803946,"twenty":-6.454764,"median":-4.494023,"eighty":-2.405157,"marketCap":7845225590},{"date":"2024-06-14","current":1.83622,"twenty":-6.411262,"median":-4.475755,"eighty":-2.37522,"marketCap":7985582733},{"date":"2024-06-21","current":1.834521,"twenty":-6.357491,"median":-4.458443,"eighty":-2.36232,"marketCap":7978195515},{"date":"2024-06-28","current":1.795452,"twenty":-6.315456,"median":-4.451397,"eighty":-2.359299,"marketCap":7808289499},{"date":"2024-07-05","current":1.780165,"twenty":-6.293959,"median":-4.43381,"eighty":-2.336521,"marketCap":7741804537},{"date":"2024-07-12","current":1.909261,"twenty":-6.284629,"median":-4.411894,"eighty":-2.31496,"marketCap":8303233110},{"date":"2024-07-15","current":1.927946,"twenty":-6.281626,"median":-4.40302,"eighty":-2.312728,"marketCap":8384492509},{"date":"2024-08-02","current":1.805074,"twenty":-6.278622,"median":-4.39535,"eighty":-2.309536,"marketCap":7850132402},{"date":"2024-08-09","current":1.693429,"twenty":-6.278622,"median":-4.366072,"eighty":-2.252116,"marketCap":8020144685},{"date":"2024-08-16","current":1.766031,"twenty":-6.246992,"median":-4.329608,"eighty":-2.236408,"marketCap":8363991829},{"date":"2024-08-23","current":1.823806,"twenty":-6.191639,"median":-4.316807,"eighty":-2.107879,"marketCap":8637614904},{"date":"2024-08-30","current":1.876896,"twenty":-6.183731,"median":-4.292175,"eighty":-2.071549,"marketCap":8889052324},{"date":"2024-09-06","current":1.903441,"twenty":-6.177405,"median":-4.262355,"eighty":-2.013004,"marketCap":9014771034},{"date":"2024-09-13","current":1.892511,"twenty":-6.151768,"median":-4.223516,"eighty":-1.918435,"marketCap":8963004506},{"date":"2024-09-20","current":1.861281,"twenty":-6.131704,"median":-4.204376,"eighty":1.697441,"marketCap":8815100142},{"date":"2024-09-27","current":1.806629,"twenty":-6.122015,"median":-4.064326,"eighty":1.738237,"marketCap":8556267503},{"date":"2024-10-04","current":1.750416,"twenty":-6.120471,"median":-4.028928,"eighty":1.751704,"marketCap":8290039647},{"date":"2024-10-11","current":1.853474,"twenty":-6.110279,"median":-4.000218,"eighty":1.762284,"marketCap":8778124050},{"date":"2024-10-18","current":1.85972,"twenty":-6.083958,"median":-3.901446,"eighty":1.777262,"marketCap":8807704923},{"date":"2024-10-25","current":1.842543,"twenty":-6.072558,"median":-3.879584,"eighty":1.781575,"marketCap":8726357523},{"date":"2024-10-31","current":1.83942,"twenty":-6.056813,"median":-3.805687,"eighty":1.791991,"marketCap":8711567086},{"date":"2024-11-08","current":1.836298,"twenty":-6.043338,"median":-3.726587,"eighty":1.795307,"marketCap":8696776650},{"date":"2024-11-15","current":1.761541,"twenty":-6.022157,"median":-3.710504,"eighty":1.796132,"marketCap":8473335020},{"date":"2024-11-22","current":1.788782,"twenty":-5.980856,"median":-3.669625,"eighty":1.795452,"marketCap":8604365974},{"date":"2024-11-29","current":1.92347,"twenty":-5.959401,"median":-3.641728,"eighty":1.799135,"marketCap":9252241246},{"date":"2024-12-06","current":1.828129,"twenty":-5.955617,"median":-3.621995,"eighty":1.805651,"marketCap":8793632907},{"date":"2024-12-13","current":1.797862,"twenty":-5.950068,"median":-3.584982,"eighty":1.808349,"marketCap":8648042958},{"date":"2024-12-20","current":1.740355,"twenty":-5.940624,"median":-3.556632,"eighty":1.808807,"marketCap":8371422056},{"date":"2024-12-27","current":1.816022,"twenty":-5.937226,"median":-3.538361,"eighty":1.814437,"marketCap":8735396928},{"date":"2025-01-03","current":1.828129,"twenty":-5.937226,"median":-3.502516,"eighty":1.814437,"marketCap":8793632907},{"date":"2025-01-10","current":1.667714,"twenty":-5.936463,"median":-3.489823,"eighty":1.814437,"marketCap":8022006178},{"date":"2025-01-17","current":1.64804,"twenty":-5.931806,"median":-3.459421,"eighty":1.81012,"marketCap":7927372712},{"date":"2025-01-24","current":1.696467,"twenty":-5.919996,"median":-3.442407,"eighty":1.808689,"marketCap":8160316630},{"date":"2025-01-31","current":1.720681,"twenty":-5.911027,"median":-3.427114,"eighty":1.808297,"marketCap":8276788589},{"date":"2025-02-07","current":1.645013,"twenty":-5.893917,"median":-3.410632,"eighty":1.807254,"marketCap":7912813717},{"date":"2025-02-14","current":-63.938672,"twenty":-5.936654,"median":-3.427114,"eighty":1.806273,"marketCap":7456591836},{"date":"2025-02-21","current":-65.590676,"twenty":-5.950068,"median":-3.43596,"eighty":1.805651,"marketCap":7649250189},{"date":"2025-02-28","current":-63.510374,"twenty":-6.028354,"median":-3.459421,"eighty":1.804623,"marketCap":7406643374},{"date":"2025-03-07","current":-64.856452,"twenty":-6.095845,"median":-3.489823,"eighty":1.803146,"marketCap":7563624254},{"date":"2025-03-14","current":-63.755116,"twenty":-6.138729,"median":-3.504703,"eighty":1.801321,"marketCap":7435185352},{"date":"2025-03-21","current":-67.120309,"twenty":-6.224851,"median":-3.540051,"eighty":1.799375,"marketCap":7827637554},{"date":"2025-03-28","current":-64.122228,"twenty":-6.294119,"median":-3.568302,"eighty":1.797622,"marketCap":7477998319},{"date":"2025-04-04","current":-61.246517,"twenty":-6.57821,"median":-3.611042,"eighty":1.797217,"marketCap":7142630074},{"date":"2025-04-11","current":-59.043845,"twenty":-6.696468,"median":-3.629292,"eighty":1.796471,"marketCap":6885752269},{"date":"2025-04-17","current":-61.307702,"twenty":-7.029605,"median":-3.656118,"eighty":1.795452,"marketCap":7149765569},{"date":"2025-04-25","current":-67.303865,"twenty":-7.203572,"median":-3.697571,"eighty":1.795404,"marketCap":7849044038},{"date":"2025-05-02","current":-70.852614,"twenty":-7.3427,"median":-3.722442,"eighty":1.794996,"marketCap":8262902723},{"date":"2025-05-09","current":-67.487421,"twenty":-7.407161,"median":-3.747314,"eighty":1.793826,"marketCap":7870450521},{"date":"2025-05-16","current":-65.835417,"twenty":-7.440032,"median":-3.863192,"eighty":1.792576,"marketCap":7677792168},{"date":"2025-05-23","current":-66.936753,"twenty":-7.514009,"median":-3.898058,"eighty":1.792422,"marketCap":7806231070},{"date":"2025-05-30","current":-44.666612,"twenty":-7.615264,"median":-3.996029,"eighty":1.791808,"marketCap":7681808591},{"date":"2025-06-06","current":-44.271332,"twenty":-7.828164,"median":-4.012794,"eighty":1.791601,"marketCap":7613827984},{"date":"2025-06-13","current":-45.338588,"twenty":-7.985677,"median":-4.058168,"eighty":1.790295,"marketCap":7797375622},{"date":"2025-06-20","current":-45.220004,"twenty":-8.052528,"median":-4.089537,"eighty":1.789085,"marketCap":7776981440},{"date":"2025-06-27","current":-45.852451,"twenty":-8.132775,"median":-4.212332,"eighty":1.786858,"marketCap":7885750412},{"date":"2025-07-03","current":-43.441245,"twenty":-8.195007,"median":-4.226706,"eighty":1.786004,"marketCap":7471068709},{"date":"2025-07-11","current":-45.733867,"twenty":-8.236009,"median":-4.268175,"eighty":1.785163,"marketCap":7865356229},{"date":"2025-07-18","current":-46.050091,"twenty":-8.440661,"median":-4.304491,"eighty":1.782373,"marketCap":7919740715},{"date":"2025-07-25","current":-44.982836,"twenty":-8.475052,"median":-4.317429,"eighty":1.780409,"marketCap":7736193076},{"date":"2025-08-01","current":-44.90378,"twenty":-8.532372,"median":-4.34784,"eighty":1.780165,"marketCap":7722596955},{"date":"2025-08-08","current":-45.837033,"twenty":-8.611161,"median":-4.372234,"eighty":1.779146,"marketCap":7883098769},{"date":"2025-08-15","current":-16.34542,"twenty":-8.663439,"median":-4.411894,"eighty":1.777563,"marketCap":8019602644},{"date":"2025-08-22","current":-16.428886,"twenty":-8.766224,"median":-4.43381,"eighty":1.776024,"marketCap":8060553806},{"date":"2025-08-29","current":-16.618548,"twenty":-8.845327,"median":-4.45492,"eighty":1.774463,"marketCap":8153608011},{"date":"2025-09-05","current":-17.495406,"twenty":-8.854277,"median":-4.470178,"eighty":1.771946,"marketCap":8583823509},{"date":"2025-09-12","current":-20.056388,"twenty":-8.876687,"median":-4.494023,"eighty":1.769108,"marketCap":9840325916},{"date":"2025-09-19","current":-21.002838,"twenty":-8.897577,"median":-4.500113,"eighty":1.767877,"marketCap":10304685501},{"date":"2025-09-26","current":-20.821899,"twenty":-8.942703,"median":-4.512292,"eighty":1.764235,"marketCap":10215910875},{"date":"2025-10-03","current":-22.241574,"twenty":-9.033505,"median":-4.556436,"eighty":1.761541,"marketCap":10912450253},{"date":"2025-10-10","current":-22.436432,"twenty":-9.13201,"median":-4.593552,"eighty":1.761463,"marketCap":11008053697},{"date":"2025-10-17","current":-24.093621,"twenty":-9.171002,"median":-4.599453,"eighty":1.761347,"marketCap":11821125436},{"date":"2025-10-24","current":-25.515863,"twenty":-9.267695,"median":-4.606312,"eighty":1.759121,"marketCap":12518924190},{"date":"2025-10-31","current":-27.571776,"twenty":-9.314846,"median":-4.630267,"eighty":1.753849,"marketCap":13527623380},{"date":"2025-11-03","current":-28.149122,"twenty":-9.32108,"median":-4.632542,"eighty":1.752882,"marketCap":13810888221}],"updateTime":1762333388293},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ROIV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568411298","title":"Guggenheim Keeps Their Buy Rating on Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568411298","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568411298?lang=en_us&edition=fundamental","pubTime":"2025-09-18 03:45","pubTimestamp":1758138324,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja maintained a Buy rating on Roivant Sciences today and set a price target of $21.00. The company’s shares opened tod...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-roivant-sciences-roiv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-roivant-sciences-roiv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV"],"gpt_icon":0},{"id":"2568792497","title":"Roivant Sciences Up Over 11%, on Track for Record High Close -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568792497","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568792497?lang=en_us&edition=fundamental","pubTime":"2025-09-17 23:05","pubTimestamp":1758121500,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd.  is currently at $15.84, up $1.66 or 11.67%. --On pace for largest percent increase since Sept. 26, 2023, when it rose 21.55%. --Currently up two consecutive days; up 13.51% over this period. --Up 31.96% from 52 weeks ago , when it closed at $12.00. --Up 74.39% from its 52-week closing low of $9.08 on April 8, 2025. --Traded as high as $16.05; highest intraday level since Dec. 20, 2021, when it hit $16.76. --Up 13.19% at today's intraday high; largest intraday percent increase since Sept. 26, 2023, when it rose as much as 25.66%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2568942134","title":"Roivant Sciences Shares up 12.2% After Co Reports Positive Trial Data for Skin, Muscle Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2568942134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568942134?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:08","pubTimestamp":1758118113,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bf1f9917e89d16c929d49ce909869251","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2568492892","title":"Roivant Sciences rises 12.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568492892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568492892?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:05","pubTimestamp":1758117925,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) is up 12.0%, or $1.70 to $15.88. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-12-0-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-12-0-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2568493498","title":"Roivant, Priovant Say Dermatomyositis Treatment Meets Main Goal in Phase 3 Study; Shares up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2568493498","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568493498?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:47","pubTimestamp":1758109665,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) and Priovant Therapeutics said Wednesday that a phase 3 study of brepocitinib to treat dermatomyositis showed a \"clinically meaningful and statistically significant improvement","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bf1f9917e89d16c929d49ce909869251","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2568493326","title":"Roivant Shares Rise On Positive Data for Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2568493326","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568493326?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:35","pubTimestamp":1758108900,"startTime":"0","endTime":"0","summary":"Shares of Roivant rose in premarket trading after the company released positive data from a phase three study of brepocitinib, a drug to treat Dermatomyositis, an autoimmune disease.The stock was up 3.8% to $14.72 after closing Tuesday up 20% so far this year.The company said brepocitinib demonstrated a statistically-significant improvement when compared to a placebo on its primary end point and all nine key secondary endpoints.More than two-thirds of patients experienced at least a moderate response from the drug with almost half experiencing a major response.The company plans to file a new drug application for the drug in the first half of next year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bf1f9917e89d16c929d49ce909869251","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Roivant Shares Rise On Positive Data for Autoimmune Disease Drug","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"2568546006","title":"Roivant Sciences Ltd - Nda Filing for Brepocitinib Planned for 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2568546006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568546006?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA2QTBPN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2568460720","title":"Roivant and Priovant Announce Positive Phase 3 Valor Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (Dm)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568460720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568460720?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA2QTBPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139"],"gpt_icon":0},{"id":"2567169158","title":"Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2567169158","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567169158?lang=en_us&edition=fundamental","pubTime":"2025-09-14 16:00","pubTimestamp":1757836800,"startTime":"0","endTime":"0","summary":"Vivek Ramaswamy sold more than $22 million worth of Roivant Sciences stock in three separate transactions last week, according to a filing with the U.S. Securities and Exchange Commission.Ramaswamy founded Roivant Sciences in 2014 and served as CEO until 2021. He has no formal role with the company today and is labeled a 10% owner in SEC filings.A Form 4 filed with the agency last week shows Ramaswamy sold 1,195,000 shares for $12.50 each on Sept. 3. This was followed by the sale of 194,933 shares for $12.92 each on Sept. 4. On Sept. 5, Ramaswamy sold an additional 385,816 shares at $12.96 apiece.The total came to 1,775,749 shares of common stock that were sold for an average price of $12.79 each, or $22.7 million. Since Ramaswamy's final sale on Sept. 5, shares have gained 10%.Hours after Trump took office on Jan. 20, Ramaswamy announced that he was backing out of the Department of Government Efficiency, a temporary advisory body he was expected to oversee alongside Tesla CEO Elon Mus","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":1},{"id":"2567618895","title":"Roivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2567618895","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567618895?lang=en_us&edition=fundamental","pubTime":"2025-09-13 02:23","pubTimestamp":1757701437,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) recently announced significant changes, notably the company's decision to initiate a $500 million share repurchase program, completing the repurchase of 148 million shares since April 2024. This strategic move was announced during a period marked by notable financial challenges, as seen in their earnings report for the quarter ended June 2025, which showed a steep decline in sales and a considerable net loss. Despite these challenges, the company's share price saw a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/roivant-sciences-roiv-announces-us500-million-share-repurcha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/roivant-sciences-roiv-announces-us500-million-share-repurcha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2566914677","title":"BRIEF-Roivant Named On Fortune Media And Great Place To Work’s 2025 Best Workplaces In Biopharma List","url":"https://stock-news.laohu8.com/highlight/detail?id=2566914677","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566914677?lang=en_us&edition=fundamental","pubTime":"2025-09-12 05:19","pubTimestamp":1757625576,"startTime":"0","endTime":"0","summary":"BRIEF-Roivant Named On Fortune Media And Great Place To Work’s 2025 Best Workplaces In Biopharma ListSept 11 (Reuters) - Roivant Sciences Ltd ROIV.O:ROIVANT NAMED ON FORTUNE MEDIA AND GREAT PLACE TO W","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nTUA3VW4J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2566911028","title":"Roivant Sciences Ltd. Conducted Its Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2566911028","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566911028?lang=en_us&edition=fundamental","pubTime":"2025-09-12 05:01","pubTimestamp":1757624477,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. held its 2025 Annual General Meeting of Shareholders on September 10, 2025. During the meeting, shareholders re-elected Matthew Gline, Keith Manchester, and Melissa Epperly as Class I directors of the company. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2026. All proposals on the agenda were approved by the shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Sept","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL5QmTqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2566197479","title":"Roivant Named on Fortune Media and Great Place to Work’s 2025 Best Workplaces in Biopharma List","url":"https://stock-news.laohu8.com/highlight/detail?id=2566197479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566197479?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:30","pubTimestamp":1757622600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nTUA3VW4J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","ROIV"],"gpt_icon":0},{"id":"2565595973","title":"Vivek Ramaswamy, 10% Owner, Reports Disposal of Common Shares in Roivant Sciences Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2565595973","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565595973?lang=en_us&edition=fundamental","pubTime":"2025-09-06 05:02","pubTimestamp":1757106127,"startTime":"0","endTime":"0","summary":"Vivek Ramaswamy, a 10% Owner, reported a disposal of common shares of Roivant Sciences Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL8FHqLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2564037168","title":"Roivant Sciences' Mosliciguat Granted Orphan Drug Designation in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2564037168","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564037168?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:46","pubTimestamp":1756986418,"startTime":"0","endTime":"0","summary":"Roivant Sciences  said Thursday that Japan's Ministry of Health, Labor and Welfare has granted orphan drug designation for mosliciguat, a potential treatment for pulmonary hypertension associated with interstitial lung disease.The designation is intended to provide key regulatory and development incentives, including priority consultation, reduced regulatory fees, and up to 10 years of market exclusivity.The company said mosliciguat is currently being evaluated in a phase 2 clinical study of approximately 120 adult patients.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2564537684","title":"Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (Ph-Ild)","url":"https://stock-news.laohu8.com/highlight/detail?id=2564537684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564537684?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:00","pubTimestamp":1756983602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nTUA6KTWG3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV"],"gpt_icon":0},{"id":"2564231834","title":"Roivant Sciences Unveils Promising Six-Month Remission Data for Potentially Transformative Graves' Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2564231834","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564231834?lang=en_us&edition=fundamental","pubTime":"2025-09-04 01:01","pubTimestamp":1756918905,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. has announced promising data from a clinical study involving batoclimab, a potential disease-modifying therapy for patients with uncontrolled Graves' disease. The study revealed that approximately 80% of the 21 patients who entered a six-month off-treatment follow-up period maintained normal thyroid function, with around 50% of these responders achieving remission without anti-thyroid drugs. These results will be presented at the 2025 Annual Meeting of the American Thyroid Association on September 11, 2025. Additionally, two potentially registrational global trials for IMVT-1402 in Graves' disease are currently enrolling, with topline readouts anticipated in 2027. Roivant will discuss these findings further during an investor call scheduled for September 3, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDLbflfFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","BK4585","BK4139","NDAQ","IE00BGHQF748.EUR","ROIV","IE00B64PRP62.GBP","BK4588","BK4007","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2564318393","title":"Roivant Unveils Durability and Treatment-Free Six-Month Remission Data With Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2564318393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564318393?lang=en_us&edition=fundamental","pubTime":"2025-09-04 01:01","pubTimestamp":1756918892,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nTUA2SZGDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4139","BK4007"],"gpt_icon":0},{"id":"2564802390","title":"Roivant Sciences Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2564802390","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564802390?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:12","pubTimestamp":1756815120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 02, 2025 08:12 ET (12:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"gpt_icon":0},{"id":"1162596606","title":"Stock Track | Roivant Sciences Plummets 5.13% as Q1 Losses Exceed Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1162596606","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162596606?lang=en_us&edition=fundamental","pubTime":"2025-08-11 21:33","pubTimestamp":1754919186,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd. (ROIV) saw its stock price plummet by 5.13% in pre-market trading on Monday following the release of its disappointing first-quarter financial results for the fiscal year 2026....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ROIV"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}]}}